A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer

E-J Choi, B-J Jung, Seung Tae Lee, H-S Yoo, E-A Shin, Hyun‐Jeong Ko, Suhwan Chang, Su‐Young Kim, Sang‐Min Jeon

Oncogene · 2017 · 120 citations · 41 references

Concepts

References

41